Rétatrutide 5 mg
Retatrutide is an investigational triple agonist of the GLP-1, GIP, and glucagon receptors. It is being studied for its potential role in weight management, metabolism, and blood glucose control.
Characteristics
- Triple GLP-1, GIP, and glucagon receptor agonist.
- 5 mg concentration.
- Long-acting formula.
- Studied for weight management and metabolic health.
- Primarily used for research.
Potential Benefits
- May promote weight loss.
- Helps reduce appetite.
- May improve blood sugar control.
- Promotes prolonged satiety.
- May support metabolic health.
Possible Side Effects
- Nausea.
- Vomiting.
- Diarrhea or constipation.
- Abdominal pain.
- Headache.
- Individual responses may vary.
Precautions
- For adult use only.
- Not recommended during pregnancy or breastfeeding.
- Long-term safety is still under investigation.
- Use under the supervision of a healthcare professional is recommended.
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, making it an appetite suppressant and the most advanced, potent metabolic drug developed to date. It stimulates the glucagon receptor, further increasing energy expenditure and fat oxidation. Clinical trials have demonstrated the most dramatic weight loss ever observed in pharmaceutical research.
-
ReferenceRétatrutide 5 mg
Comments (0)
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent